Evidence map›Paper›PMID 12748278›Full record

ArticleMolecular and cellular biology2003

p27Kip1 inhibition of GRB2-SOS formation can regulate Ras activation.

Stephanie J Moeller, Elizabeth D Head, Robert J Sheaff

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. MEN4 andEndocrine-related cancer · 2017
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Stephanie J MoellerUniversity of Minnesota Cancer Center, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Elizabeth D Head
Robert J Sheaff
University of Minnesota · USInstitute of Molecular Biology and Biophysics · RU

Funding

REGULATION OF THE CELL CYCLE INHIBITOR P27KIPL BY REDOXR21CA087267 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SHEAFF, ROBERT J · 2001 to 2002
$223k
NCI NIH HHS CA-87267
6 · The paper itself

Abstract

p27(Kip1) (p27) is often inappropriately downregulated in aggressive human cancers. Although p27 can inhibit cyclin-dependent kinases (CDKs), low p27 does not always correlate with increased CDK activity. Furthermore, cells derived from p27(-/-) mice respond to antimitogens, maintain restriction point control, and do not deregulate CDKs. Thus, disruption of a p27 function other than CDK inhibition may contribute to the disease state. A yeast two-hybrid screen identified growth factor receptor-bound protein 2 (GRB2) as a p27 binding partner. We now demonstrate that p27 can inhibit GRB2 function by blocking its association with the guanine nucleotide exchange factor SOS. Endogenous p27 is rapidly exported from the nucleus to the cytoplasm in response to mitogen stimulation, where it binds GRB2 concomitant with a decrease in GRB2-associated SOS. As predicted, mitogen-stimulated p27(-/-) cells maintained their GRB2-SOS complexes for significantly longer. The Ras/mitogen-activated protein kinase pathway does not appear to be deregulated in cells lacking p27 despite excess GRB2-SOS, suggesting that additional control mechanisms are present. A transient-transfection approach was employed to show that p27 can inhibit Ras activation by targeting GRB2 and further revealed that the CDK and GRB2 inhibitory functions of p27 are separable and distinct. Thus, p27 downregulation may compromise control of Ras, one of the most common oncogenic events in human cancer.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCell Cycle ProteinsCell LineCulture Media, Serum-FreeCyclin-Dependent Kinase Inhibitor p27Cyclin-Dependent KinasesCyclin EEnzyme ActivationEnzyme InhibitorsFatty Acids, UnsaturatedFibroblastsGRB2 Adaptor ProteinHumansMacromolecular SubstancesMAP Kinase Signaling SystemAdaptor Proteins, Signal TransducingCdkn1b protein, mouseCell Cycle ProteinsCulture Media, Serum-FreeCyclin-Dependent Kinase Inhibitor p27Cyclin-Dependent KinasesCyclin EEnzyme InhibitorsFatty Acids, UnsaturatedGRB2 Adaptor ProteinGRB2 protein, humanGrb2 protein, mouseleptomycin BMacromolecular SubstancesMitogen-Activated Protein Kinase KinasesMitogensProteinsras ProteinsRecombinant Fusion ProteinsSon of Sevenless ProteinsTumor Suppressor Proteins

Identifiers

PMID12748278
PMCPMC155227
OpenAlexW2162481290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.